Recent Company News

• 11:02 PM ET May 12, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 03:06 AM ET May 12, 2026
  

  Santen Pharmaceutical reports Q4 IFRS net income attributable ¥15.56B, +83% vs year-ago ¥8.51B (¥1561.5000, 0)

• 01:59 AM ET Apr 23, 2026
  

  Santen Pharmaceutical releases Sustainability Report 2025 (¥1665.5000, -17.5)

• 11:13 PM ET Apr 07, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (111 total)

• 11:14 PM ET Apr 06, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (58 total)

• 11:01 PM ET Apr 05, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (60 total)

• 11:07 PM ET Apr 01, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (65 total)

• 09:53 AM ET Apr 01, 2026
  

  SMBC Nikko initiates 4521.JP, 4536.JP

• 11:10 PM ET Mar 31, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (32 total)

• 01:45 AM ET Feb 05, 2026
  

  Santen Pharmaceutical reports Q3 core net income attributable ¥9.62B vs FactSet ¥9.52B [3 est, ¥9.04-10.43B] (¥1774.0000, 0)